Small-molecule SMAC mimetics as new cancer therapeutics

被引:169
作者
Bai, Longchuan
Smith, David C.
Wang, Shaomeng
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Int Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
关键词
SMAC mimetics; Apoptosis; Inhibitors; NF-KAPPA-B; X-LINKED INHIBITOR; TRAIL-INDUCED APOPTOSIS; MIXED LINEAGE KINASE; CELL-DEATH COMPLEX; C-RAF KINASE; STRUCTURAL BASIS; IAP PROTEINS; ANTAGONISTS INDUCE; PROMOTES APOPTOSIS;
D O I
10.1016/j.pharmthera.2014.05.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers. Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy. XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are critical regulators of cell death and survival and are attractive targets for new cancer therapy. The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2. In the last decade, intense research efforts have resulted in the design and development of several small-molecule SMAC mimetics now in clinical trials for cancer treatment. In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-molecule SMAC mimetics as novel cancer treatments. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:82 / 95
页数:14
相关论文
共 149 条
[61]   Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac [J].
Huang, YH ;
Rich, RL ;
Myszka, DG ;
Wu, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :49517-49522
[62]   Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas [J].
Hurwitz, H. ;
Pitot, H. ;
Strickler, J. ;
Sorensen, J. M. ;
Leopold, L. ;
Brill, J. ;
Smith, D. C. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 :25-25
[63]  
Imoto I, 2002, CANCER RES, V62, P4860
[64]  
Imoto I, 2001, CANCER RES, V61, P6629
[65]   cIAP1, cIAP2, and XIAP Act Cooperatively via Nonredundant Pathways to Regulate Genotoxic Stress-Induced Nuclear Factor-κB Activation [J].
Jin, Hyung-Seung ;
Lee, Dong-Hee ;
Kim, Dong-Hwan ;
Chung, Ji-Hye ;
Lee, Seul-Ji ;
Lee, Tae H. .
CANCER RESEARCH, 2009, 69 (05) :1782-1791
[66]   Nuclear factor-κB in cancer development and progression [J].
Karin, Michael .
NATURE, 2006, 441 (7092) :431-436
[67]   Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma [J].
Keats, Jonathan J. ;
Fonseca, Rafael ;
Chesi, Marta ;
Schop, Roelandt ;
Baker, Angela ;
Ching, Wee-Joo ;
Van Wier, Scott ;
Tiedemann, Rodger ;
Shi, Chang-Xin ;
Sebag, Michael ;
Braggio, Esteban ;
Henry, Travis ;
Zhu, Yuan-Xiao ;
Fogle, Homer ;
Price-Troska, Tammy ;
Ahmann, Gregory ;
Mancini, Catherine ;
Brents, Leslie A. ;
Kumar, Shaji ;
Greipp, Philip ;
Dispenzieri, Angela ;
Bryant, Barb ;
Mulligan, George ;
Bruhn, Laurakay ;
Barrett, Michael ;
Valdez, Riccardo ;
Trent, Jeff ;
Stewart, A. Keith ;
Carpten, John ;
Bergsagel, P. Leif .
CANCER CELL, 2007, 12 (02) :131-144
[68]   Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers [J].
Krajewska, M ;
Kim, H ;
Kim, C ;
Kang, HY ;
Welsh, K ;
Matsuzawa, S ;
Tsukamoto, M ;
Thomas, RG ;
Assa-Munt, N ;
Piao, Z ;
Suzuki, K ;
Perucho, M ;
Krajewski, S ;
Reed, JC .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5451-5461
[69]  
Krajewska M, 2003, CLIN CANCER RES, V9, P4914
[70]   The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells [J].
Krepler, Clemens ;
Chunduru, Srinivas K. ;
Halloran, Molly B. ;
He, Xu ;
Xiao, Min ;
Vultur, Adina ;
Villanueva, Jessie ;
Mitsuuchi, Yasuhiro ;
Neiman, Eric M. ;
Benetatos, Christopher ;
Nathanson, Katherine L. ;
Amaravadi, Ravi K. ;
Pehamberger, Hubert ;
McKinlay, Mark ;
Herlyn, Meenhard .
CLINICAL CANCER RESEARCH, 2013, 19 (07) :1784-1794